NO337013B1 - Nye azaibicykliske forbindelser, fremgangsmåte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem - Google Patents

Nye azaibicykliske forbindelser, fremgangsmåte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem Download PDF

Info

Publication number
NO337013B1
NO337013B1 NO20064160A NO20064160A NO337013B1 NO 337013 B1 NO337013 B1 NO 337013B1 NO 20064160 A NO20064160 A NO 20064160A NO 20064160 A NO20064160 A NO 20064160A NO 337013 B1 NO337013 B1 NO 337013B1
Authority
NO
Norway
Prior art keywords
group
formula
compounds
pharmaceutically acceptable
optionally substituted
Prior art date
Application number
NO20064160A
Other languages
English (en)
Norwegian (no)
Other versions
NO20064160L (no
Inventor
Patrick Casara
Brian Lockhart
Pierre Lestage
Alain Dhainaut
Anne-Marie Chollet
Lionel Bert
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20064160L publication Critical patent/NO20064160L/no
Publication of NO337013B1 publication Critical patent/NO337013B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
NO20064160A 2004-02-20 2006-09-14 Nye azaibicykliske forbindelser, fremgangsmåte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem NO337013B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0401690A FR2866647B1 (fr) 2004-02-20 2004-02-20 Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2005/000382 WO2005089747A1 (fr) 2004-02-20 2005-02-18 Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
NO20064160L NO20064160L (no) 2006-09-14
NO337013B1 true NO337013B1 (no) 2015-12-21

Family

ID=34833930

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064160A NO337013B1 (no) 2004-02-20 2006-09-14 Nye azaibicykliske forbindelser, fremgangsmåte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem

Country Status (29)

Country Link
US (1) US7576120B2 (https=)
EP (1) EP1720544B1 (https=)
JP (1) JP4519861B2 (https=)
KR (1) KR100885104B1 (https=)
CN (2) CN100577160C (https=)
AR (3) AR047685A1 (https=)
AT (1) ATE389398T1 (https=)
AU (1) AU2005224129B2 (https=)
BR (1) BRPI0507830A (https=)
CA (1) CA2555216C (https=)
CY (1) CY1108529T1 (https=)
DE (1) DE602005005456T2 (https=)
DK (1) DK1720544T3 (https=)
EA (1) EA010300B1 (https=)
ES (1) ES2303233T3 (https=)
FR (1) FR2866647B1 (https=)
GE (1) GEP20094578B (https=)
HR (1) HRP20080184T5 (https=)
MA (1) MA28342A1 (https=)
ME (1) ME01400B (https=)
MY (1) MY137282A (https=)
NO (1) NO337013B1 (https=)
NZ (1) NZ548898A (https=)
PL (1) PL1720544T3 (https=)
PT (1) PT1720544E (https=)
RS (1) RS50577B (https=)
SI (1) SI1720544T1 (https=)
WO (1) WO2005089747A1 (https=)
ZA (1) ZA200606558B (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1717235A3 (en) * 2005-04-29 2007-02-28 Bioprojet Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
EP1717234A1 (en) * 2005-04-29 2006-11-02 Bioprojet Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
US20090023731A1 (en) * 2007-03-22 2009-01-22 Arete Therapeutics, Inc. Soluble epoxide hydrolase inhibitors
FR2932479A1 (fr) * 2008-06-13 2009-12-18 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2937251B1 (fr) * 2008-10-16 2011-03-18 Servier Lab Utilisation du 4-{3-°hexahydrocyclopenta°c!pyrrol-2(1h)-yl! propoxy}benzamide pour l'obtention de medicaments destines au traitement des troubles du sommeil
FR2953513B1 (fr) 2009-12-09 2011-12-23 Servier Lab Nouveaux derives azabicyclo[3.2.0]hept-6-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2953514B1 (fr) 2009-12-09 2011-12-23 Servier Lab Nouveaux derives azabicyclo[3.2.0]hept-3-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2953515B1 (fr) 2009-12-09 2011-12-23 Servier Lab Nouveaux derives du type hexahydrocyclopenta[b]pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2953521B1 (fr) * 2009-12-09 2011-11-18 Servier Lab Nouveaux derives azabicyclo[3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2974729B1 (fr) 2011-05-02 2013-04-19 Servier Lab Nouvelle association entre le 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide et un inhibiteur de l'acetylcholinesterase et les compositions pharmaceutiques qui la contiennent
FR2976285B1 (fr) * 2011-06-08 2013-05-24 Servier Lab Procede de synthese et forme cristalline du chlorhydrate de 4-{3-[cis-hexahydrocypenta[c]pyrrol-2(1h)-yl]propoxy}benzamide ainsi que les compositions pharmaceutiques qui la contiennent
FR2976286B1 (fr) * 2011-06-08 2013-05-24 Servier Lab 4-{3-[trans-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, son procede de preparation et les compositions pharmaceutiques qui le contiennent
EP2789608A4 (en) 2011-12-08 2015-07-01 Taisho Pharmaceutical Co Ltd PHENYLPYRROLDERIVAT
FR2983732B1 (fr) 2011-12-09 2013-11-22 Servier Lab Nouvelle association entre le 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}pharmaceutiques qui la contiennent
TW201343636A (zh) * 2011-12-27 2013-11-01 大正製藥股份有限公司 苯基三唑衍生物
CN103183632A (zh) * 2011-12-29 2013-07-03 山东方明药业集团股份有限公司 一种3-氮杂双环辛烷盐酸盐的提纯方法
FR2999179A1 (fr) * 2012-12-07 2014-06-13 Servier Lab Procede de synthese d'un sel d'addition a un acide pharmaceutiquement acceptable du 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, ainsi que les formes cristallines associees
FR3003466B1 (fr) * 2013-03-22 2015-08-07 Servier Lab Utilisation du 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide pour le traitement des douleurs neuropathiques
EP3594206A1 (en) * 2018-07-09 2020-01-15 Abivax Phenyl-n-quinoline derivatives for treating a rna virus infection
EP3594205A1 (en) 2018-07-09 2020-01-15 Abivax Phenyl-n-aryl derivatives for treating a rna virus infection
CN111377846B (zh) * 2018-12-27 2022-05-24 江苏恩华药业股份有限公司 一种哌嗪苯甲酰胺类衍生物及其应用
CN111377911B (zh) * 2018-12-27 2022-05-24 江苏恩华药业股份有限公司 一种吗啉苯甲酰胺类化合物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2962496A (en) * 1957-01-28 1960-11-29 Geschickter Fund Med Res Nu-substituted-3-azabicyclooctanes [3: 3: 0] and salts thereof
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
EP1299352B1 (en) * 2000-06-30 2005-12-28 Elan Pharmaceuticals, Inc. Compounds to treat alzheimer's disease
BR0108088A (pt) * 2000-07-13 2004-04-06 Abbott Lab Pirrolidinas 1,3-dissubstituìdas e 1,3,3-trissubstituìdas como ligandos receptores de histamina-3 e suas aplicações terapêuticas
FR2827288B1 (fr) * 2001-07-12 2003-10-31 Servier Lab Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
US20070197625A1 (en) 2007-08-23
JP2007523135A (ja) 2007-08-16
DE602005005456D1 (de) 2008-04-30
JP4519861B2 (ja) 2010-08-04
RS50577B (sr) 2010-05-07
CA2555216A1 (fr) 2005-09-29
SI1720544T1 (sl) 2008-06-30
CN100577160C (zh) 2010-01-06
ZA200606558B (en) 2008-01-08
MY137282A (en) 2009-01-30
FR2866647A1 (fr) 2005-08-26
AR047685A1 (es) 2006-02-01
KR20060114382A (ko) 2006-11-06
HK1123789A1 (en) 2009-06-26
AU2005224129A1 (en) 2005-09-29
EP1720544A1 (fr) 2006-11-15
EP1720544B1 (fr) 2008-03-19
EA010300B1 (ru) 2008-08-29
KR100885104B1 (ko) 2009-02-20
ATE389398T1 (de) 2008-04-15
CN1921848A (zh) 2007-02-28
CA2555216C (fr) 2011-10-11
CN101230033B (zh) 2011-03-09
PT1720544E (pt) 2008-05-08
ES2303233T3 (es) 2008-08-01
CY1108529T1 (el) 2014-04-09
HRP20080184T5 (en) 2008-10-31
EA200601512A1 (ru) 2007-02-27
DK1720544T3 (da) 2008-07-21
NO20064160L (no) 2006-09-14
ME01400B (en) 2013-12-20
MA28342A1 (fr) 2006-12-01
BRPI0507830A (pt) 2007-07-10
GEP20094578B (en) 2009-01-12
AU2005224129B2 (en) 2010-08-12
PL1720544T3 (pl) 2008-05-30
AR089451A2 (es) 2014-08-27
WO2005089747A1 (fr) 2005-09-29
HRP20080184T3 (hr) 2008-05-31
CN101230033A (zh) 2008-07-30
US7576120B2 (en) 2009-08-18
AR094601A2 (es) 2015-08-12
FR2866647B1 (fr) 2006-10-27
NZ548898A (en) 2010-06-25
DE602005005456T2 (de) 2009-04-09

Similar Documents

Publication Publication Date Title
NO337013B1 (no) Nye azaibicykliske forbindelser, fremgangsmåte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem
US20050192286A1 (en) Ligands of melanocortin receptors and compositions and methods related thereto
RU2660897C2 (ru) Новые соединения в качестве ингибиторов гистондеацетилазы 6 и содержащие их фармацевтические композиции
JP5580364B2 (ja) 医薬として活性なピロリジン誘導体
RU2591190C2 (ru) Новые 4-амино-n-гидроксибензамиды в качестве ингибиторов hdac для лечения рака
SK42693A3 (en) Indoline derivatives with amidic group
TR201906325T4 (tr) Tetrazolon sübstitüeli dihidropiridinon MGAT2 inhibitörleri.
KR20070103454A (ko) 1,5-디아릴피롤 유도체, 그의 제조 방법, 및 치료제에서의그의 적용
JP7492033B2 (ja) ヒストン脱アセチル化酵素６阻害剤としての１，３，４－オキサジアゾール誘導体化合物、およびそれを含む医薬組成物
JP7200258B2 (ja) デュアルの５－ｈｔ２ａおよび５－ｈｔ６受容体アンタゴニストとしての新しいインドールおよびベンゾイミダゾール誘導体
JP5142152B2 (ja) ４，５−ジアリールピロール誘導体、この調製方法および治療におけるこの使用
CN104884436B (zh) 苯并氮杂衍生物及其医药用途
JP2010514824A (ja) 置換ｎ−（４−シアノ−１ｈ−ピラゾール−３−イル）メチルアミン誘導体、これらの調製およびこれらの治療的使用
JP2012136437A (ja) ヘテロ５員環化合物
CN101679457B (zh) 作为nk拮抗剂的哌嗪和[1,4]二氮杂环庚烷衍生物
HK1123789B (en) Azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
MXPA06009346A (en) Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
HK40033115B (zh) 作为双重5-ht2a和5-ht6受体拮抗剂的吲哚和苯并咪唑衍生物

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees